| 2021 |
NUPR1 drives ferroptosis resistance by transcriptionally upregulating LCN2, which reduces iron accumulation and subsequent oxidative damage. LCN2 depletion mimics NUPR1 deficiency with respect to ferroptosis induction, and re-expression of LCN2 restores ferroptosis resistance in NUPR1-deficient cells. |
NanoString gene expression, shRNA knockdown (NUPR1 and LCN2), pancreas-specific conditional knockout mice, enforced LCN2 re-expression, ferroptosis induction assays with erastin, mouse models of pancreatitis |
Nature communications |
High |
33510144
|
| 2017 |
NUPR1 maintains autolysosomal efflux by transcriptionally inducing the SNARE protein SNAP25, which forms a complex with the lysosomal SNARE-associated protein VAMP8. NUPR1 depletion impairs autophagic flux and induces massive cytoplasmic vacuolization and premature senescence. |
NUPR1 depletion (RNAi), transcriptional induction assays, co-immunoprecipitation of SNAP25/VAMP8 complex, autophagy flux assays, senescence assays in vitro and tumor suppression in vivo |
Autophagy |
High |
29130426
|
| 2008 |
NUPR1 forms a complex with p53 and p300 and binds the p21 promoter to transcriptionally upregulate p21 expression, conferring resistance to doxorubicin and Taxol. |
Co-immunoprecipitation, chromatin immunoprecipitation (ChIP) on p21 promoter, reporter assays, doxorubicin/Taxol resistance assays |
Current cancer drug targets |
Medium |
18690848
|
| 2009 |
NUPR1 (p8) binds MSL1, a histone acetyltransferase (HAT)-associated protein, and negatively regulates MSL1-dependent DNA repair activity following gamma-irradiation. MSL1 binds the DNA-damage-associated protein 53BP1 to facilitate DNA repair, and p8 interaction inhibits this repair activity. NUPR1 expression is transiently induced then downregulated after irradiation, presumably to allow MSL1-associated DNA repair to proceed. |
Protein-protein interaction assays, cell-based DNA repair assays, gamma-irradiation, 53BP1 knockdown experiments |
Journal of cellular physiology |
Medium |
19650074
|
| 2013 |
Nupr1 and MSL1 form a complex in the nucleus in response to DNA damage, essential for cell survival in response to cisplatin. MSL1 binds Nupr1 with an affinity of ~2.8 µM (entropically driven), and MSL1 binds chemically damaged DNA with ~1.2 µM affinity. The binding region of Nupr1 in its complexes is always disordered ('fuzzy'). |
Spectroscopic and biophysical methods (fluorescence, ITC, NMR), Co-IP in nucleus, cisplatin survival assays |
PloS one |
High |
24205110
|
| 2017 |
NUPR1 binds the C-terminal region of Polycomb RING1B (C-RING1B) with affinity in the low micromolar range (~10 µM). The binding region of NUPR1 was mapped by NMR to a hydrophobic patch at the 30s region (around Ala33). Mutation of Ala33 to Gln reduces binding. This interaction is inhibited by trifluoperazine and occurs in cellulo (by protein ligation assays). |
NMR, computational docking, isothermal titration calorimetry, site-directed mutagenesis (Ala33Gln, Thr68Gln), protein ligation assays in cellulo |
Proceedings of the National Academy of Sciences of the United States of America |
High |
28720707
|
| 2019 |
ZZW-115 (a TFP-derived compound) binds NUPR1 around residue Thr68 in the nuclear localization signal (NLS) region, competing with importins and thereby completely inhibiting nuclear translocation of NUPR1. This mechanism underlies its anticancer (necroptosis-inducing) activity. |
Biophysical binding assays (ITC, fluorescence), computer modeling, nuclear translocation assays, cell death mechanistic assays (necroptosis markers), xenograft tumor models |
The Journal of clinical investigation |
High |
30920390
|
| 2020 |
NUPR1 interacts with several hundreds of proteins including importins, DNA repair proteins, and key SUMO pathway factors. ZZW-115 competes with importins for binding to the NLS region of NUPR1, inhibiting nuclear translocation. NUPR1 inhibition reduces SUMOylation of DNA damage response (DDR) proteins; recombinant NUPR1 directly stimulates the SUMOylation machinery in a cell-free system. |
Interactome mass spectrometry, nuclear translocation assays, SUMOylation assays in cells and cell-free system with recombinant NUPR1, genotoxic agent sensitization assays |
JCI insight |
High |
32780723
|
| 2012 |
NUPR1 confers chemoresistance in p53-deficient breast cancer cells by promoting Akt-mediated phosphorylation and subsequent cytoplasmic re-localization of p21 and activation of anti-apoptotic Bcl-xL, defining a NUPR1-PI3K/Akt-phospho-p21 axis. |
NUPR1 knockdown/overexpression, p21 localization by immunofluorescence/fractionation, Akt inhibitor experiments, chemoresistance assays |
FEBS letters |
Medium |
22858377
|
| 2012 |
Nupr1 protects pancreatic cancer cells from metabolic stress-induced autophagy-associated cell death through regulation of Aurora kinase A (AURKA). Nupr1 knockdown enhances DNA damage, alters gene expression related to DNA repair and cell cycle, and AURKA expression is partially regulated by Nupr1. |
Affymetrix transcriptome analysis, RNAi silencing, AURKA overexpression, DNA damage markers (Western blot and immunofluorescence), autophagy markers, human TMA analysis |
Clinical cancer research |
Medium |
22899799
|
| 2018 |
Inactivation of NUPR1 induces mitochondrial failure (loss of membrane potential, increased ROS, decreased OXPHOS/ATP production), relocalization of mitochondria near the ER, and downregulation of ER stress response genes, leading to programmed necrosis (reversed by Necrostatin-1 but not Z-VAD-FMK). In vivo, NUPR1 protects acinar cells from necrosis during ER stress in acute pancreatitis. |
NUPR1 knockdown, mitochondrial membrane potential assays, OXPHOS/ATP measurement, ROS measurement, mitochondria/ER co-localization imaging, transcriptomic analysis, thapsigargin/brefeldin A/tunicamycin treatment, acute pancreatitis mouse model, Necrostatin-1 and Z-VAD-FMK rescue experiments |
Scientific reports |
High |
30451898
|
| 2021 |
NUPR1 binds PARP1 in the nucleus and inhibits PARP1 activity in vitro. Inhibition of NUPR1 (genetically or by ZZW-115) induces hyperPARylation, mitochondrial catastrophe (decreased membrane potential, superoxide production, increased ROS, cytosolic Ca2+ elevation), and cell death through non-canonical Parthanatos (without AIF translocation from mitochondria). This is rescued by PARP inhibitor olaparib or NAD+ precursor NMN. |
Proteomic interactome, Co-IP (NUPR1-PARP1), in vitro PARP1 activity assay with recombinant NUPR1 and NUPR1 mutants, PARylation assays, mitochondrial function assays, olaparib rescue, NAD+/NADH ratio measurement |
Communications biology |
High |
35869257
|
| 2021 |
NUPR1 inhibitor ZZW-115 induces ROS accumulation and ferroptotic cell death in a mitochondria-dependent manner. ZZW-115 causes loss of GSH/GPX antioxidant activity, hydroperoxided lipid accumulation, and mitochondrial morphological changes. TFAM (key regulator of mitochondrial biogenesis) is downregulated by ZZW-115, and forced TFAM expression rescues mitochondrial alterations, ROS production, and cell death. |
ROS assays, lipid peroxidation assays, ferroptosis inhibitor (ferrostatin-1) rescue, GSH/GPX activity assays, mitochondrial morphology imaging, TFAM overexpression rescue, xenograft models |
Cell death discovery |
High |
34599149
|
| 2012 |
NUPR1 transcriptionally regulates DNMT1 expression to modulate genome-wide DNA methylation levels, thereby acting as a gene modifier of Kras(G12D)-induced senescence. Nupr1 inactivation in mice leads to increased β-galactosidase-positive cells and upregulation of senescence marker genes via the FoxO3a-Skp2-p27(Kip1)-pRb-E2F pathway. |
Nupr1 genetic knockout in KrasG12D mice, β-galactosidase senescence assays, gene expression analysis, DNMT1 expression assays, 5-aza-2'-deoxycytidine treatment, RNAi in human pancreatic cancer cells |
Cell death and differentiation |
Medium |
24902898
|
| 2015 |
Nupr1 acts as a gene modifier of Kras(G12D)-induced senescence by regulating Dnmt1 expression and genome-wide DNA methylation levels, preventing senescence in lung and pancreatic cells to allow transformation. |
Nupr1-/- mouse models with KrasG12D in pancreas and lung, DNA methylation analysis, DNMT1 expression, senescence assays, 5-aza-2'-deoxycytidine treatment |
Scientific reports |
Medium |
26617245
|
| 2012 |
NUPR1 transcriptionally regulates human NUPR1 expression is activated by TGFβ at the transcriptional level through SMAD proteins binding to a functional TGFβ-response element located in the 5'-UTR of the NUPR1 gene. |
Promoter-reporter assays, SMAD ChIP, 5'-UTR deletion/mutation analysis, TGFβ treatment experiments |
The Biochemical journal |
Medium |
22738338
|
| 2016 |
NUPR1 overexpression decreases levels of the histone acetyltransferase MOF (KAT8) and H4K16 acetylation. Cr(VI)-induced reduction of H4K16 acetylation is substantially compromised by NUPR1 knockdown, indicating NUPR1 mediates the Cr(VI)-induced loss of this cancer-associated epigenetic mark. |
NUPR1 overexpression and knockdown, H4K16ac Western blot, MOF expression assays, Cr(VI) treatment, anchorage-independent growth assays, cell transformation assays |
PloS one |
Medium |
27285315
|
| 2020 |
Phosphorylation of Thr68 in the NLS region of NUPR1 induces a conformational switch from random-coil to a turn-like structure, which hampers binding to importin α3 (Impα3). Positive charges at Lys65 and Lys69 are critical for importin binding. The NLS region of NUPR1 binds Impα3 with low micromolar affinity (1.7–27 µM depending on mutant). |
2D-1H-NMR (NOE analysis), fluorescence spectroscopy, ITC, molecular docking, phospho-mimetic and alanine mutants of NLS peptides |
Biomolecules |
High |
32933064
|
| 2021 |
NUPR1 interacts with eIF2α and its phosphorylated form (p-eIF2α) in the nucleus. Loss of NUPR1 results in maintained eIF2α phosphorylation and slower post-stress protein synthesis recovery, implicating NUPR1 in resolution of the PERK branch of the unfolded protein response. |
Co-immunoprecipitation, proximity ligation assays (PLA), bioinformatic analysis of interactome, click chemistry for nascent protein synthesis, NUPR1 knockout mouse pancreatic acinar cells |
The FEBS journal |
Medium |
33403797
|
| 2022 |
NUPR1 interacts with aryl hydrocarbon receptor (AhR) and promotes its degradation via the autophagy-lysosome pathway and decreased nuclear translocation, thereby suppressing CYP transcription. This reduces ROS production and confers radioresistance in hepatocellular carcinoma. |
Co-immunoprecipitation, RNA sequencing, AhR nuclear translocation assays, pharmacological AhR activation, lysosome inhibition assays, xenograft models, NUPR1 knockdown |
BMC medicine |
Medium |
36258210
|
| 2022 |
NUPR1 promotes proliferation and metastasis in oral squamous cell carcinoma by directly increasing TFE3 transcription factor activity, thereby maintaining autophagic flux and lysosomal function. |
Tandem mass tag quantitative proteomics, NUPR1 stable knockdown, TFE3 activity assays, autophagy flux assays, in vitro and in vivo tumor growth and metastasis models |
Signal transduction and targeted therapy |
Medium |
35462576
|
| 2024 |
NUPR1 induces droplet formation via liquid-liquid phase separation (LLPS) and is required for stress granule (SG) formation in pancreatic cancer cells. KrasG12D mutation induces NUPR1 overexpression and promotes SG development; enforced NUPR1 expression alone induces SG formation independently of KrasG12D. Inhibition of NUPR1 by ZZW-115 impedes SG formation and selectively kills KrasG12D-expressing cells via caspase 3 activation. |
LLPS assays, stress granule imaging, ZZW-115 pharmacological inhibition, NUPR1 genetic overexpression, KrasG12D mouse model (KC mice), caspase 3 activation, LDH release, PanIN analysis in vivo |
EMBO molecular medicine |
High |
38360999
|
| 2023 |
NUPR1 binds PADI4 (peptidyl-arginine deiminase 4) mainly in the nucleus, with a dissociation constant of ~18 µM. The binding region of NUPR1 involves the hydrophobic patch around Ala33 (mapped by NMR and confirmed by Ala33 mutagenesis). |
NMR (binding region mapping), ITC (affinity measurement), site-directed mutagenesis (Ala33), proximity ligation assays (PLA) in cellulo, immunofluorescence, molecular modelling |
Journal of molecular biology |
High |
36858171
|
| 2020 |
NUPR1 binds PKP1 (Plakophilin 1) at the armadillo-repeat domain with ~10 µM affinity; the binding region of NUPR1 is the 30s region (around Ala33). This interaction occurs in the nucleus as confirmed by proximity ligation assays. |
Fluorescence spectroscopy, NMR, molecular docking, isothermal titration calorimetry, protein ligation assays in cellulo, immunofluorescence |
International journal of biological macromolecules |
Medium |
33385445
|
| 2021 |
Nupr1 mediates TGF-β-induced myofibroblast activation (α-SMA expression, collagen synthesis) by initiating the Smad3 signaling pathway in kidney fibroblasts and epithelial cells undergoing EMT. Nupr1 deficiency attenuates UUO-induced renal fibrosis in mice, and TFP (NUPR1 inhibitor) alleviates fibrosis. |
Nupr1-/- mice with UUO model, TGF-β stimulation of primary fibroblasts and epithelial cells, Smad3 phosphorylation assays, α-SMA/collagen expression, TFP pharmacological inhibition |
FASEB journal |
Medium |
33617091
|
| 2016 |
NUPR1 silencing in HCC cells reduced expression of RELB, IER3, and RUNX2 genes and downregulated NF-κB and ERK signaling nodes, demonstrating a NUPR1/RELB/IER3/RUNX2 regulatory pathway in hepatocarcinogenesis. |
NUPR1 stable knockdown, gene expression profiling (microarray), RELB/IER3/RUNX2 knockdown experiments, cell growth/migration/invasion assays, sorafenib sensitivity assays |
Cell death & disease |
Medium |
27336713
|
| 2013 |
NUPR1 promotes cell cycle progression in pancreatic beta cells by suppressing Ccna2 and Tcf19 promoter activities. Nupr1 deletion increases beta cell mass through enhanced islet cell proliferation. |
Nupr1-/- mice, BrdU incorporation for proliferation, luciferase promoter reporter assays for Ccna2 and Tcf19, gene arrays, morphometric analysis of islets |
Diabetologia |
Medium |
23900510
|
| 2015 |
NUPR1 knockdown in liver cancer cells suppressed invasion in a Ca2+-signaling-dependent manner. NUPR1 promoter binding assay identified granulin as a key downstream effector of NUPR1 in a mitochondrial defect-related pathway. |
NUPR1 knockdown, invasion assays, Ca2+ signaling inhibition, NUPR1-centric network analysis, promoter binding assay for granulin |
Hepatology |
Medium |
26173068
|
| 2022 |
NUPR1 interacts with SREBP1 and upregulates lipogenic gene expression (FASN), resulting in lipid accumulation that promotes hepatocellular carcinoma progression. Pharmacological or genetic blockade of the NUPR1-SREBP1/FASN pathway reduces tumor growth in vitro and in vivo. |
Co-immunoprecipitation (endogenous NUPR1-SREBP1), FASN and lipid accumulation assays, NUPR1 knockdown/overexpression, xenograft tumor models |
Cell death discovery |
Medium |
36307402
|
| 2022 |
NUPR1 promotes proliferation and metastasis in breast cancer by activating TFE3 transcription, thereby inducing autophagy. NUPR1 knockdown inhibits malignancy formation and metastasis in vivo. |
NUPR1 knockdown, TFE3 transcription assays, autophagy marker analysis, breast cancer in vitro and xenograft in vivo models |
Experimental cell research |
Low |
35660538
|
| 2016 |
Nupr1 in the METH-exposure context acts upstream of the CHOP-P53-PUMA/Beclin1 pathway to induce mitochondrial apoptosis in endothelial cells. CHOP upregulation by Nupr1 leads to Beclin1 induction, which forms a ternary complex with Bcl-2 to reduce free Bcl-2 and promote cytochrome c release and caspase activation. |
shRNA/siRNA silencing of Nupr1, CHOP, P53, PUMA, Beclin1; Western blot for pathway markers; apoptosis assays; cytochrome c translocation assay; in vitro and in vivo (rat) models |
Cell death & disease |
Medium |
27031958
|
| 2023 |
SETD4 methyltransferase represses NUPR1 transcription by catalyzing H3K27 trimethylation (H3K27me3) at the NUPR1 locus, thereby inactivating the Akt pathway and suppressing prostate cancer development. |
SETD4 knockdown/overexpression, H3K27me3 ChIP, NUPR1 expression assays, Akt pathway analysis, prostate cancer cell proliferation and cell cycle assays |
Cancer letters |
Medium |
37879429
|
| 2022 |
Loss of Nupr1 in hematopoietic stem cells (HSCs) activates quiescent HSCs and confers engraftment advantage. Nupr1 inhibits p53 expression in HSCs; rescue of p53 offsets the engraftment advantage of Nupr1-/- HSCs, placing Nupr1 upstream of p53 in HSC quiescence regulation. |
Nupr1 conditional knockout, serial transplantation assays, p53 rescue experiments, in vitro expansion assays, quiescence analysis by flow cytometry |
Haematologica |
Medium |
33299232
|
| 2023 |
Nupr1 regulates HtrA1 (a serine protease) expression in osteoblasts/osteocytes, thereby suppressing SMAD1 signaling and osteoblastogenesis. Nupr1 deficiency reduces HtrA1 expression and enhances SMAD1 signaling; Nupr1 overexpression enhances HtrA1 expression. |
Nupr1-KO mice, differential gene expression analysis in osteocytes, in vitro primary osteoblast cultures with Nupr1 overexpression/deficiency, SMAD1 phosphorylation assays, senescence marker analysis |
Journal of cellular physiology |
Medium |
36715607
|
| 2025 |
Tumor-derived lactate upregulates NUPR1 expression in macrophages via histone lactylation, and NUPR1 in turn inhibits ERK and JNK signaling pathways, promoting M2 macrophage polarization and increased expression of PD-L1 and SIRPA. |
scRNA-seq, functional in vitro and in vivo assays, histone lactylation analysis, ERK/JNK signaling pathway assays, NUPR1 knockdown in macrophages, PD-1 blockade combination experiments |
Advanced science |
Medium |
40305758
|
| 2025 |
NR3C1 (glucocorticoid receptor) directly regulates NUPR1 transcription in response to psychological stress, which in turn increases SNAI2 (Slug) expression to drive EMT and ovarian tumor metastasis. |
Chronic restraint stress mouse model, NR3C1 transcriptional regulation assay at NUPR1 promoter, SNAI2 expression assays, EMT marker analysis, NR3C1-NUPR1 correlation in patient data |
Acta pharmaceutica Sinica. B |
Medium |
40654365
|
| 2025 |
FTO (m6A demethylase) stabilizes NUPR1 mRNA by targeting the +451 m6A site, thereby preventing YTHDF2-mediated degradation of NUPR1 mRNA, leading to increased NUPR1 protein and downstream LCN2/FTH1-mediated iron homeostasis and chemoresistance in colorectal cancer. |
CRISPR/Cas9 FTO knockout cells and mice, m6A site mapping, YTHDF2 interaction assays, mRNA stability assays, LCN2/FTH1 expression analysis, chemotherapy sensitivity assays |
Redox biology |
Medium |
40334546
|
| 2023 |
WTAP promotes NUPR1 expression via m6A modification in an eIF3A-mediated manner (m6A-EIF3A), which in turn upregulates LCN2 and suppresses ferroptosis in triple-negative breast cancer. |
m6A dot blot assay, NUPR1 mRNA stability assay, RIP assay (eIF3a-NUPR1 interaction), NUPR1 silencing, LCN2 knockdown, ferroptosis markers (GSH/GSSG, Fe2+) |
Biochemical genetics |
Medium |
37477758
|
| 2021 |
NUPR1 promotes FTH1 transcription in HCC cells (via the circPIAS1/miR-455-3p/NUPR1/FTH1 axis), enhancing iron storage and conferring ferroptosis resistance. CircPIAS1 sequesters miR-455-3p to upregulate NUPR1. |
RNA immunoprecipitation, luciferase reporter assays, ChIP (NUPR1 on FTH1 promoter), FISH, NUPR1 inhibitor ZZW-115, ferroptosis assays, xenograft models |
Molecular cancer |
Medium |
38802795
|
| 2021 |
NUPR1 promotes PPAR-α signaling via the UPR, protecting liver from lipotoxic injury. NUPR1 loss-of-function in mice fed high-fat diet results in impaired UPR activation and reduced PPAR-α signaling, leading to increased hepatic steatosis. |
Nupr1-/- mice on high-fat diet, UPR pathway analysis, PPAR-α signaling assays, patient liver biopsy analysis, immunohistochemistry, mRNA analysis |
FASEB journal |
Medium |
33566371
|
| 2024 |
NUPR1 mediates METH-induced pulmonary arterial smooth muscle cell (PASMC) phenotypic conversion from contractile to synthetic by activating STIM1 expression, which opens store-operated calcium entry (SOCE) channels, promoting Ca2+ influx and pulmonary artery remodeling. |
NUPR1 expression analysis in human/mouse lung specimens, PASMC NUPR1 knockdown/overexpression, STIM1 expression assays, Ca2+ influx (SOCE) measurement, pulmonary artery remodeling histology, right ventricular systolic pressure measurement |
Cell biology and toxicology |
Medium |
38347241
|
| 2019 |
Amphipathic helical peptides bind to NUPR1 around Ala33 and C-terminus residues (low micromolar Kd ~3 µM), inhibiting NUPR1-RING1B interaction in cellulo. The Thr68Gln mutant of NUPR1 does not interact with these peptides. |
Fluorescence, circular dichroism, NMR, ITC, docking/MD simulations, proximity ligation assays (in cellulo for NUPR1-RING1B interaction inhibition), site-directed mutagenesis (Thr68Gln) |
Biochimica et biophysica acta. General subjects |
Medium |
29530795
|
| 2008 |
Loss of NUPR1 (p8) in mice results in delayed LHB (luteinizing hormone beta subunit) expression during gonadotroph development, ovarian maturation delay (absence of corpora lutea at 8 weeks), and age-related testicular germ cell loss resembling Sertoli-cell-only syndrome, demonstrating a role for NUPR1 in temporal regulation of LHB and gonadal function. |
Nupr1-/- mouse model, RT-qPCR for LHB/FSHB/GATA2/CGA/TSH expression at embryonic time points, gonadal histology, corpora lutea assessment |
Biology of reproduction |
Medium |
18495683
|
| 2019 |
AP-1 (via JUN binding sites) transcriptionally regulates NUPR1 in response to nickel exposure. Knockdown of JUN or FOS suppresses NUPR1 induction by Ni. Deletion of the upstream JUN binding site in the NUPR1 promoter reduces promoter activity. |
Luciferase reporter assay with NUPR1 promoter, JUN binding site deletion (site-directed mutagenesis), JUN/FOS knockdown experiments, NUPR1 promoter cloning |
Oncology reports |
Medium |
33649793
|